Loading...

Loading...

Novo Nordisk México Names Patricia Field as Director General
By MBN Staff - Mon, 01/19/2026 - 09:01
Novo Nordisk México appoints Patricia Field as Director General to strengthen innovation, access to care, and its chronic disease strategy.
https://mexicobusiness.news/tag/chronic-diseases
More Health
Scaling Interventions Could Reduce NCD Burden: McKinsey
By Sofía Garduño - Wed, 09/24/2025 - 11:30
Scaling proven health interventions could save 28 million lives annually and add US$11 trillion to global GDP by 2050, says McKinsey.
Dräger’s Atlan A350 Series Gains US DoD Security Certification
By MBN Staff - Wed, 08/13/2025 - 10:08
Dräger’s Atlan A350 anesthesia workstation series earns US DoD cybersecurity certification, securing patient data in operating rooms.
Novartis Reports Positive Phase III Results for Sjögren’s Drug
By MBN Staff - Wed, 08/13/2025 - 09:02
Novartis reports Phase III success for ianalumab, a potential first targeted treatment for Sjögren’s disease.
Rising Health Costs Strain Mexican Households
By Aura Moreno - Tue, 08/12/2025 - 10:57
Health costs in Mexico have been rising sharply since 2018, increasing financial strain for households.
Global Thyroid Disorder Market to Take Off by 2030
By MBN Staff - Fri, 08/01/2025 - 11:49
AI, early screening, and personalized care push the thyroid disorder market to a projected US$21 billion by 2030, with growth in Mexico and globally.
J&J, Medtronic, Novo Nordisk in the Spotlight: The Week in Health
By Sofía Garduño - Thu, 07/24/2025 - 08:59
This week J&J files for psoriasis drug, Medtronic expands device use in the European Union, and Novo Nordisk launches an e-commerce store in Mexico.
Expanding Access to Molecular Medicine to Enhance Care
By Sofía Garduño - Wed, 07/23/2025 - 12:14
Molecular medicine offers superior cancer detection capabilities, which can improve treatment outcomes, says Grupo JUAMA’s Juan Pablo Vilar.
Reimagining Healthcare for a World Under Pressure
By María Jesús Salido Rojo - Wed, 07/23/2025 - 07:30
Healthcare faces challenges that include chronic diseases and workforce shortages. Digital care offers value-based solutions, writes María Salido.

Chronic Diseases Drive Growth in Global GPCR Targeting Market
By MBN Staff - Mon, 07/21/2025 - 17:12
The GPCR targeting market is set to grow to US$6.1 billion by 2029, driven by chronic diseases and advances in drug discovery technologies.